Jabbour Jerome D 4
4 · Matinas BioPharma Holdings, Inc. · Filed Dec 15, 2023
Insider Transaction Report
Form 4
Jabbour Jerome D
DirectorPresident and CEO
Transactions
- Award
Stock Option (right to Buy)
2023-12-15+3,500,000→ 3,500,000 totalExercise: $0.25Exp: 2033-12-15→ Common Stock (3,500,000 underlying)
Footnotes (1)
- [F1]The option award was made in accordance with the terms of the Issuer's Amended and Restated 2013 Equity Incentive Plan. The option vests as to 25% of the shares on December 15, 2024 with the remaining shares to vest in equal monthly installments on the last day of each month over a period of 36 months commencing December 31, 2024.